Ellsworth Advisors »

Celldex Therapeutics shares owned by Ellsworth Advisors

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Ellsworth Advisors from 13F filings

Historical chart of Ellsworth Advisors investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Ellsworth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Ellsworth Advisors

Quarter filed Position value Share count Share price at filing
2026-09-30 $958k 30k 32.41

More positions owned by Ellsworth Advisors

Harbor Etf Trust Comm All Wea Etf (HGER)
NVIDIA Corporation (NVDA)
Spdr Gold Tr Gold Shs (GLD)
First Tr Exchange-traded First Tr Enh New (FTSM)
Microsoft Corporation (MSFT)
Apple (AAPL)
Johnson & Johnson (JNJ)
Advanced Micro Devices (AMD)
Broadcom (AVGO)
Eaton Corp SHS (ETN)
Alphabet Cap Stk Cl C (GOOG)
Chevron Corporation (CVX)
Cisco Systems (CSCO)
Enterprise Products Partners (EPD)
Amgen (AMGN)

View all positions for Ellsworth Advisors

Top funds holding Celldex Therapeutics

Wellington Management Company
BlackRock
Kynam Capital Management
State Street Corporation
FMR
Vanguard Capital Management
Deep Track Capital
Logos Global Management
Geode Capital Management
Eversept Partners
Goldman Sachs Group
Commodore Capital
Bellevue Group
Baker Bros. Advisors
Millennium Management

View all funds holding Celldex Therapeutics